Chronic Lymphocytic Leukemia

Filter By:
Patients often wonder, could having one CLL treatment now prevent them from taking another option in the future? Leading CLL researchers, Dr. David Maloney and Dr. John Pagel, discuss what approaches could limit therapy choices down the road and stress the importance of a long-term planning conversation between doctor and patient. Get email aler...
by:patientpower | 322 views
Recently, many approved and developing CLL therapies have aimed to inhibit rather than destroy cancer cells, often replacing the more toxic chemotherapy standard. BTK and PI3K inhibitor classes have become familiar terms to CLL patients as more drugs are added to the list of treatment options. But what other classes are emerging? Dr. David Maloney,...
by:patientpower | 242 views
Often, patients wonder, "What is small lymphocytic leukemia (SLL) and how does it differ from chronic lymphocytic leukemia (CLL)?" A leading CLL expert, Dr. John Pagel, explains the biology of SLL and the approach to treatment, including a drug recently approved for the disease. Get email alerts | http://www.p......
by:patientpower | 1141 views
Gwyneth Stafford CLL & Lymphoma Nurse Specialist at Cambridge University Hospitals gives her perspective on the challenges that CLL patients experience when managing their symptoms. A theme running through the video is the importance of keeping the medical team informed and working together to find strategies and support to reduce impact. Q...
by:PatientPowerEU | 324 views
With many therapy options to consider, how can patients best discuss their CLL treatment options with their doctor? A CLL expert from Seattle Cancer Care Alliance, Dr. David Maloney, discusses his approach to determining when to treat and what factors—includi​ng age and pre-existing conditions—he con...
by:patientpower | 624 views
Doctors and patients alike have shown excitement over a new generation of novel agents for the treatment of non-Hodgkin lymphoma that allows some patients to take continuous, oral medications with less toxicity than traditional chemotherapy. While these drugs may offer kinder, gentler treatment path...
by:patientpower | 967 views
In this video Professor Chris Pepper of The Cardiff CLL Research Group, Institute of Cancer & Genetics at Cardiff University tells us a little about himself and how he became involved in CLL research, the work of the CLL research team and the Cancer Research Genetics Building and provides us wit...
by:PatientPowerEU | 798 views
Different drug combinations have different toxicity profiles, associated complications and efficacy. Requiring lengthy discussion between patients and their doctor and treatment at a centre experienced in their delivery and care of patients being treated with them. Q1) Many patient’s have hea...
by:PatientPowerEU | 1760 views
The new targeted therapies will require discipline and engagement by patients to ensure they take their medications to stay in remission. Longer term the research community is working towards novel none chemo combinations that may produce a durable MRD status, removing the need then for continued m...
by:PatientPowerEU | 1510 views
Much discussion is required between the patient and doctor when understanding where you are, as tests may be better at predicting for populations and there is much individual variation to consider. Q1) What are the most important clinical tests for CLL patients to take? Q2) What genetic techniqu...
by:PatientPowerEU | 1269 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)